Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

There are numerous causes of memory and thinking difficulties. Many, including Alzheimer's disease, are treatable. Others, such as depression, thyroid problems, severe nutritional deficiency, or ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

A research project has shown that an experimental model of Alzheimer’s disease can be successfully treated with a commonly used anti-inflammatory drug. A team led by Dr David Brough from The ...

Alzheimer's leans to memory loss then progressive failure of mental and physical functions Early results in a new treatment for one of the most common forms of dementia have been "absolutely ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing ...

Once daily oral administration of blarcamesine meaningfully slowed clinical decline in early Alzheimer's disease patients, demonstrating a favorable safety profile with no associated neuroimaging ...